Physician profile
Tracy P Wallace
NPI 1720306558
$1,920.33
in general payments reported to CMS, 2019-2025
23 companies · $531 in 2025
The $531 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $54.91 · 2021: $179 · 2022: $300 · 2023: $247 · 2024: $486 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $293.66 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $233.34 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Supernus Pharmaceuticals, INC. | $206.03 | 2021-2025 | Qelbree, Qelbree |
| Pfizer INC. | $197.09 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $183.21 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $118.69 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $115.37 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $92.60 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $80.64 | 2024-2025 | |
| Cranial Technologies, INC | $62.40 | 2024-2025 | Doc Band |
| Sobi, INC | $57.45 | 2020-2023 | |
| Sanofi Pasteur INC. | $48.38 | 2019-2025 | |
| Vertical Pharmaceuticals, LLC | $35.45 | 2024-2025 | Relexxii |
| Verrica Pharmaceuticals INC. | $32.39 | 2025 | Ycanth |
| Tris Pharma INC | $32.12 | 2024-2025 | Dyanavel Xr |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $18.91 | 2024 | Crysvita |
| Astrazeneca Pharmaceuticals LP | $18.59 | 2024 | Flumist Quadrivalent |
| Neos Therapeutics, LP | $18.00 | 2022 | |
| Krystal Biotech INC | $17.36 | 2025 | Vyjuvek |
| Aytu Biopharma, INC. | $16.91 | 2024 | Karbinal |
| Cumberland Pharmaceuticals, INC. | $14.98 | 2025 | Kristalose |
| Phadia US INC. | $14.88 | 2022 | |
| Alk-Abello, INC | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.